HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 557742Generated: October 31, 2026
Lithium Hydroxide → 4-(5-Oxo-4,5-dihydro-[1,2,4]oxadiazol-3-yl)-cyclohexanecarboxylic acid
https://huagongshe.com/reaction/557742
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Lithium Hydroxide | HCID 3939 | — |
| Reactant | 4-(5-Oxo-4,5-dihydro-[1,2,4]oxadiazol-3-yl)-cyclohexanecarboxylic acid methyl ester | HCID 136206823 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 4-(5-Oxo-4,5-dihydro-[1,2,4]oxadiazol-3-yl)-cyclohexanecarboxylic acid | HCID 136206824 | 20% |
Reaction Steps
A mixture of aqueous lithium hydroxide (215 mg, 5.13 mmol, 10 mL H2O), 4-(5-oxo-4,5-dihydro-[1,2,4]oxadiazol-3-yl)-cyclohexanecarboxylic acid methyl ester (580 mg, 2.56 mmol) and THF (40 mL) were stirred at room temperature for 5 hr. The reaction was then concentrated, diluted with aqueous sodium hydroxide (0.1 M, 100 mL) washed with ethyl acetate (100 mL). The basic solution was acidified with concentrated HCl and extracted with ethyl acetate (125 mL). The organic layer was washed with brine (100 mL), dried over sodium sulfate, concentrated, and dried from dichloromethane to give 4-(5-oxo-4,5-dihydro-[1,2,4]oxadiazol-3-yl)-cyclohexanecarboxylic acid (104 mg, 20%) as a white solid. LCMS calcd for C9H12N2O4 (m/e) 212, obsd 213 (M+H) and 211 (M−H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08058299B2 |
|---|
| Source dataset | uspto-grants-2011_11 |
|---|
| ORD ID | ord-9448c3b77ba448daa22048083cde02e8 |
|---|
| Source note | uspto-grants-2011_11 |
|---|